Where can Singapore take the lead in alternative proteins?
Tessa Oh
SINGAPORE is investing heavily in alternative proteins in a bid to become a world leader – but its status as a global hub, especially for manufacturing, may be threatened as other countries catch up.
Alternative proteins do not involve the slaughter of animals; they may be plant-based, fermented using microbes, or cultivated from animal cells.
In Singapore, investments in such proteins multiplied to US$169.8 million by 2022, from just US$5.9 million in 2019, according to think tank Good Food Institute (GFI). This was part of the US$562 million Asia-Pacific total in 2022, up from US$42 million in 2019.
TRENDING NOW
Lamborghini-driving boss of Eminent Frog Porridge charged with S$3.8 million tax evasion, money laundering
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
Palm oil stocks set to surge as Indonesia said to be scaling back export overhaul: analysts
Soon Su Lin to step down as Frasers Property Singapore CEO; Tan Wee Hsien named successor